Health insurance company Oscar has raised the target price range of its IPO to between $36 and $38 per share, up from $32 to $34 apiece. The new midpoint price would give Oscar a fully diluted valuation of around $9.4 billion. New York-based Oscar was valued at $3.2 billion in 2018, according to a PitchBook estimate. Alphabet is Oscar's largest outside backer with 18.1% of Class A shares, followed by Founders Fund (16.2%). Co-founder Joshua Kushner's Thrive Capital owns 32.9 million Class B shares, which will give the firm 75.9% of the voting power after the IPO.